State Street Corp Has $279.06 Million Holdings in Chemed Co. (NYSE:CHE)

State Street Corp increased its holdings in Chemed Co. (NYSE:CHE - Free Report) by 0.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 464,354 shares of the company's stock after buying an additional 3,564 shares during the quarter. State Street Corp owned about 3.09% of Chemed worth $279,063,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. American National Bank & Trust acquired a new position in shares of Chemed during the 3rd quarter valued at $61,000. GAMMA Investing LLC lifted its position in shares of Chemed by 60.5% in the third quarter. GAMMA Investing LLC now owns 138 shares of the company's stock worth $83,000 after purchasing an additional 52 shares in the last quarter. Quarry LP lifted its position in Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company's stock worth $103,000 after buying an additional 166 shares in the last quarter. Sound Income Strategies LLC purchased a new stake in shares of Chemed during the third quarter worth $201,000. Finally, Farther Finance Advisors LLC lifted its holdings in shares of Chemed by 2,314.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company's stock valued at $203,000 after buying an additional 324 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on CHE. Royal Bank of Canada reduced their price objective on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a research note on Tuesday, November 5th. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research report on Saturday, November 30th.

Chemed Stock Up 0.1 %

CHE traded up $0.53 during trading on Wednesday, reaching $547.79. 132,951 shares of the company's stock were exchanged, compared to its average volume of 86,191. The company has a market capitalization of $8.24 billion, a P/E ratio of 27.60, a PEG ratio of 2.34 and a beta of 0.46. The business has a 50 day moving average price of $572.96 and a 200 day moving average price of $564.91. Chemed Co. has a fifty-two week low of $523.33 and a fifty-two week high of $654.62.

Chemed (NYSE:CHE - Get Free Report) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to analyst estimates of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm's revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.32 EPS. As a group, research analysts forecast that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.37%. The ex-dividend date of this dividend was Monday, November 18th. Chemed's payout ratio is presently 10.11%.

Insider Buying and Selling at Chemed

In other news, Director George J. Walsh III sold 400 shares of the company's stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares of the company's stock, valued at $1,819,893.62. This represents a 11.61 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. This trade represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,132 shares of company stock worth $3,003,502. 3.32% of the stock is currently owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.